The hOGG1 Ser326Cys polymorphism and prostate cancer risk: A meta-analysis of 2584 cases and 3234 controls

BMC Cancer

Volumn 11, Issue , 2011, Pages

  Zhang, Hongtuan ^a   Xu, Yong ^a   Zhang, Zhihong ^a   Li, Liang ^a  

^a SECOND HOSPITAL OF TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE; DNA GLYCOSYLTRANSFERASE; SERINE; OXOGUANINE GLYCOSYLASE 1, HUMAN;

ARTICLE; CANCER GROWTH; CANCER RISK; CANCER SUSCEPTIBILITY; DISEASE ASSOCIATION; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENOTYPE; HOGG1 GENE; HUMAN; POPULATION RESEARCH; PROSTATE CANCER; RISK REDUCTION; SYSTEMATIC REVIEW; CASE CONTROL STUDY; ENZYMOLOGY; GENETIC PREDISPOSITION; GENETICS; MALE; META ANALYSIS; PROSTATE TUMOR; RISK; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

CASE-CONTROL STUDIES; DNA GLYCOSYLASES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATIC NEOPLASMS; RISK FACTORS;

EID: 80052666224     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-11-391     Document Type: Article

References (23)

1. Cheng KC, Cahill DS, Kasai H, Nishimura S, Loeb LA. 8- Hydroxyguanine, an abundant form of oxidative DNA damage, causes G-T and A-C substitutions. J Biol Chem 1992, 267:166-172.
2. Hazra TK, Hill JW, Izumi T, Mitra S. Multiple DNA glycosylases for repair of 8-oxoguanine and their potential in vivo functions. Prog Nucleic Acid Res Mol Biol 2001, 68:193-205.
3. Boiteux S, Radicella JP. The human OGG1 gene: structure, functions, and its implication in the process of carcinogenesis. Arch Biochem Biophys 2000, 377:1. 10.1006/abbi.2000.1773, 10775435.
4. Weiss JM, Goode EL, Ladiges WC, Ulrich CM. Polymorphic variation in hOGG1 and risk of cancer: a review of the functional and epidemiologic literature. Mol Carcinog 2005, 42:127-141. 10.1002/mc.20067, 15584022.
5. Kohno T, Shinmura K, Tosaka M, Tani M, Kim SR, Sugimura H, Nohmi T, Kasai H, Yokota J. Genetic polymorphisms and alternative splicing of hOGG1gene that is involved in repair of 8-hydroxyguanine in damaged DNA. Oncogene 1998, 16:3219-3225. 10.1038/sj.onc.1201872, 9681819.
6. Dherin C, Radicella JP, Dizdaroglu M, Boiteux S. Excision of oxidatively damaged DNA bases by the human alpha-hOgg1 protein and the polymorphic alpha-hOgg1(Ser326Cys) protein which is frequently found in human populations. Nucleic Acids Res 1999, 27:4001-4007. 10.1093/nar/27.20.4001, 148667, 10497264.
7. Vodicka P, Stetina R, Polakova V, Tulupova E, Naccarati A, Vodickova L, Kumar R, Hanova M, Pardini B, Slyskova J, Musak L, De Palma G, Soucek P, Hemminki K. Association of DNA repair polymorphisms with DNA repair functional outcomes in healthy human subjects. Carcinogenesis 2007, 28:657-64.
8. Yun SJ, Ha YS, Chae Y, Kim JS, Kim IY, Kim WJ. The hOGG1 mutant genotype is associated with prostate cancer susceptibility and aggressive clinicopathological characteristics in the Korean population. Annals of Oncology
9. Zhang J, Dhakal IB, Greene G, Lang NP, Kadlubar FF. Polymorphisms in hOGG1 and XRCC1 and risk of prostate cancer: effects modified by plasma antioxidants. Urology 2010, 75:779-785. 10.1016/j.urology.2009.08.063, 2850942, 19914697.
10. Lavender NA, Komolafe OO, Benford M, Brock G, Moore JH, Vancleave TT, States JC, Kittles RA, Kidd LC. No Association between Variant DNA Repair Genes and Prostate Cancer Risk among Men of African descent. Prostate 2010, 70:113-119. 2798907, 19760636.
11. Dhillon VS, Yeoh E, Fenech M. DNA repair gene polymorphisms and prostate cancer risk in South Australia-results of a pilot study. Urol Oncol
12. Nock NL, Cicek MS, Li L, Liu X, Rybicki BA, Moreira A, Plummer SJ, Casey G, Witte JS. Polymorphisms in estrogen bioactivation, detoxification and oxidative DNA base excision repair genes and prostate cancer risk. Carcinogenesis 2006, 27:1842-1848. 10.1093/carcin/bgl022, 16569655.
13. Nam RK, Zhang WW, Jewett MA, Trachtenberg J, Klotz LH, Emami M, Sugar L, Sweet J, Toi A, Narod SA. The use of genetic markers to determine risk for prostate cancer at prostate biopsy. Clin Cancer 2005, 11:8391-8397.
14. Chen L, Elahi A, Pow-Sang J, Lazarus P, Park J. Association between polymorphism of human oxoguanine glycosylase 1 and risk of prostate cancer. J Urol 2003, 170:2471-2474. 10.1097/01.ju.0000087498.23008.bb, 14634453.
15. Xu J, Zheng SL, Turner A, Isaacs SD, Wiley KE, Hawkins GA, Chang BL, Bleecker ER, Walsh PC, Meyers DA, Isaacs WB. Associations between hOGG1 sequence variants and prostate cancer susceptibility. Cancer Res 2002, 62:2253-2257.
16. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959, 22:719-748.
17. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986, 7:177-188. 10.1016/0197-2456(86)90046-2, 3802833.
18. de Boer JG. Polymorphisms in DNA repair and environmental interactions. Mutat Res 2002, 509:201-210. 10.1016/S0027-5107(02)00217-8, 12427539.
19. Berwick M, Vineis P. Markers of DNA repair and susceptibility to cancer in humans: an epidemiologic review. J Natl Cancer Inst 2000, 92:874-97. 10.1093/jnci/92.11.874, 10841823.
20. Ioannidis JP, Ntzani EE, Trikalinos TA, Contopoulos-Ioannidis DG. Replication validity of genetic association studies. Nat Genet 2001, 29:306-309. 10.1038/ng749, 11600885.
21. Munafò M. Replication validity of genetic association studies of smoking behavior: what can meta-analytic techniques offer?. Nicotine Tob Res 2004, 6:381-382. 10.1080/14622200410001676369, 15203812.
22. Kang TS, Jin SK, Lee JE, Woo SW, Roh J. Comparison of genetic polymorphisms of the NAT2 gene between Korean and four other ethnic groups. J Clin Pharm Ther 2009, 34:709-718. 10.1111/j.1365-2710.2009.01065.x, 20175805.
23. Dianat SS, Margreiter M, Eckersberger E, Finkelstein J, Kuehas F, Herwig R, Ayati M, Lepor H, Djavan B. Gene polymorphisms and prostate cancer: the evidence. BJU Int 2009, 104:1560-1572. 10.1111/j.1464-410X.2009.08973.x, 20053187.